DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
175 hedge funds and large institutions have $707M invested in DIPLOMAT PHARMACY, INC. in 2017 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 75 increasing their positions, 37 reducing their positions, and 12 closing their positions.
175% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 12
103% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 37
32% more call options, than puts
Call options by funds: $1.89M | Put options by funds: $1.44M
13% more funds holding
Funds holding: 155 → 175 (+20)
9% less capital invested
Capital invested by funds: $778M → $707M (-$71.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$76M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$10M |
| 3 |
SAM
Sentinel Asset Management
Montpelier,
Vermont
|
+$7.26M |
| 4 |
D.E. Shaw & Co
New York
|
+$6.13M |
| 5 |
FAM
Fred Alger Management
New York
|
+$6.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$21M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$20M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$18.5M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$11.8M |
| 5 |
SAM
Senzar Asset Management
New York
|
-$7.1M |
DPLO Hedge Fund Activity: Q2 2017 in Review
175 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q2 2017, worth a combined $707M — down 9.1% from $778M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new DPLO positions and 12 closed out — a net gain of 21 holders — while 75 added to existing stakes and 37 trimmed.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $76M. The largest seller was T. Rowe Price Associates, cutting an estimated $21M.
- 175 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q2 2017, up from 155 in Q1 2017.
- Funds reported $707M of DIPLOMAT PHARMACY, INC. stock for Q2 2017, down 9.1% quarter-over-quarter.
- 33 funds opened new DIPLOMAT PHARMACY, INC. positions in Q2 2017 and 12 closed out, a net change of +21 holders.
- The largest DIPLOMAT PHARMACY, INC. buyer in Q2 2017 was Janus Henderson Group, an estimated $76M added.
- The largest DIPLOMAT PHARMACY, INC. seller in Q2 2017 was T. Rowe Price Associates, an estimated $21M sold.
Based on aggregated 13F filings for Q2 2017.